Other abnormalities included microphthalmia in 2/14 patients (14.3%) and corneal opacities in 2/14 patients (although one patient had also been diagnosed with Schnyder’s corneal dystrophy secondary to a concomitant mutation in UBIAD1). This evidence concerns the gene UBIAD1 and microphthalmia.